
Akira Sawa, MD
Highlights
Languages
- English
Gender
MaleJohns Hopkins Affiliations:
- Johns Hopkins School of Medicine Faculty
About Akira Sawa
Professional Titles
- Director, Johns Hopkins Schizophrenia Center
Primary Academic Title
Professor of Psychiatry and Behavioral Sciences
Background
Psychiatrist and neuroscientist Akira Sawa is the director of the Johns Hopkins Schizophrenia Center; Professor of psychiatry, neuroscience, biomedical engineering, genetic medicine, and pharmacology at the Johns Hopkins University School of Medicine; and Professor of mental health at the Johns Hopkins Bloomberg School of Public Health. He started his Johns Hopkins career as a tenure-track faculty member in 2002. Since 2012, he has served as the Director and Innovation Chair of the Johns Hopkins Schizophrenia Center. The Center focuses on patient care, research, education and public outreach for psychotic disorders and severe mental disorders. Accordingly, Sawa’s goal is to integrate the frontline science with daily patient care in an effective manner. He has maintained federal center grants over the decade, leading multidisciplinary clinical/translational projects to address mechanistic questions for major mental illnesses, such as schizophrenia, mood disorders and Alzheimer’s disease, with a particular emphasis on early detection and early intervention of these conditions. He was elected as a fellow to the Association of American Physicians in 2020, and as an AAAS fellow in 2024. He has also served for multiple academic societies and clinical charities as an advisory board, council member, and fellow in the US and UK.
Centers and Institutes
Additional Academic Titles
Professor of Genetic Medicine, Professor of Pharmacology and Molecular Sciences, Professor of Biomedical Engineering, Professor of Neuroscience
Contact for Research Inquiries
600 N. Wolfe Street
Baltimore, MD 21287
Phone: (410) 955-4726
Fax: (410) 614-1792
asawa1@jhmi.edu
Research Interests
Clinical Psychiatry
Selected Publications
Prolonged HPA axis dysregulation in postpartum depression associated with adverse life experiences: a cross-species translational study. Niwa et al. Nature Mental Health, 2024, 2:594-604.
The miR-124-AMPAR pathway connectspolygenic risks with behavioral changes shared between schizophrenia and bipolar disorder. Namkung et al, Neuron, 2023, 111:220-235.
Prenatal immune stress blunts microglia reactivity which impairs neurocircuitry. Hayes et al, Nature, 2022, 610:327-324.
A multimodal study of a first episode psychosis cohort: potential markers of antipsychotic treatment resistance. Yang et al, Molecular Psychiatry, 2022, 27:1184-1191.
Adolescent stress-induced epigenetic control of dopaminergic neurons via glucocorticoids. Niwa et al. Science, 2013, 339:335-339.